Refujia Gomez

6.1k total citations
15 papers, 414 citations indexed

About

Refujia Gomez is a scholar working on Pathology and Forensic Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Refujia Gomez has authored 15 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 5 papers in Rheumatology and 3 papers in Molecular Biology. Recurrent topics in Refujia Gomez's work include Multiple Sclerosis Research Studies (11 papers), Systemic Sclerosis and Related Diseases (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Refujia Gomez is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Systemic Sclerosis and Related Diseases (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Refujia Gomez collaborates with scholars based in United States, Switzerland and Germany. Refujia Gomez's co-authors include Bruce Cree, Stephen L. Hauser, Robin Lincoln, Douglas S. Goodin, Daniel Pelletier, Darin T. Okuda, Michaela F. George, Sergio E. Baranzini, A. Beheshtian and Jorge R. Oksenberg and has published in prestigious journals such as Nature Communications, Brain and Neurology.

In The Last Decade

Refujia Gomez

14 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Refujia Gomez United States 9 291 99 78 68 65 15 414
Antonio Martı́nez-Yélamos Spain 12 279 1.0× 71 0.7× 157 2.0× 43 0.6× 79 1.2× 33 451
Marcus Vinícius Magno Gonçalves Brazil 13 226 0.8× 93 0.9× 125 1.6× 39 0.6× 47 0.7× 54 469
Wanda Castro-Borrero United States 8 227 0.8× 65 0.7× 61 0.8× 73 1.1× 56 0.9× 12 368
Reza Vosoughi Canada 9 194 0.7× 52 0.5× 107 1.4× 62 0.9× 55 0.8× 22 354
AK Hedström Sweden 9 365 1.3× 66 0.7× 57 0.7× 151 2.2× 71 1.1× 10 486
Jamie Greenfield Canada 10 232 0.8× 94 0.9× 88 1.1× 48 0.7× 62 1.0× 20 459
Frank Hoffmann Germany 12 240 0.8× 42 0.4× 120 1.5× 74 1.1× 28 0.4× 31 450
Virginia Meca‐Lallana Spain 13 364 1.3× 54 0.5× 155 2.0× 32 0.5× 33 0.5× 42 487
Priscila O. Barros Brazil 15 300 1.0× 81 0.8× 126 1.6× 232 3.4× 66 1.0× 21 596
Antonio Cortese Italy 14 307 1.1× 35 0.4× 144 1.8× 58 0.9× 71 1.1× 25 463

Countries citing papers authored by Refujia Gomez

Since Specialization
Citations

This map shows the geographic impact of Refujia Gomez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Refujia Gomez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Refujia Gomez more than expected).

Fields of papers citing papers by Refujia Gomez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Refujia Gomez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Refujia Gomez. The network helps show where Refujia Gomez may publish in the future.

Co-authorship network of co-authors of Refujia Gomez

This figure shows the co-authorship network connecting the top 25 collaborators of Refujia Gomez. A scholar is included among the top collaborators of Refujia Gomez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Refujia Gomez. Refujia Gomez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chitnis, Tanuja, Ferhan Qureshi, Michael J. Becich, et al.. (2024). Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis. Nature Communications. 15(1). 4297–4297. 10 indexed citations
2.
Bostrom, Alan, Alyssa Nylander, Ann Lazar, et al.. (2024). Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple Sclerosis. Neurology. 104(2). e210228–e210228. 5 indexed citations
3.
Bostrom, Alan, Ann Lazar, Refujia Gomez, et al.. (2023). Accelerated Worsening in Serum Neurofilament Light Chain Levels and Multiple Sclerosis Functional Composite in Women with MS after Menopause (S9.009). Neurology. 100(17_supplement_2). 1 indexed citations
4.
Kaplan, Tamara, Valerie J. Block, Anne M. Suskind, et al.. (2022). Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 62. 103793–103793. 5 indexed citations
5.
Rowles, William, Antoine Lizée, Arno Klein, et al.. (2020). A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development. Journal of Medical Internet Research. 22(7). e15605–e15605. 22 indexed citations
6.
Romeo, Andrew R., William Rowles, Patrick Barba, et al.. (2020). An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis. Multiple Sclerosis Journal. 27(9). 1432–1441. 12 indexed citations
7.
Krysko, Kristen M., Roland G. Henry, Bruce Cree, et al.. (2019). Telomere Length Is Associated with Disability Progression in Multiple Sclerosis. Annals of Neurology. 86(5). 671–682. 49 indexed citations
8.
Cekanaviciute, Egle, Anne‐Katrin Pröbstel, Tessel F. Runia, et al.. (2018). Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria. mSystems. 3(6). 61 indexed citations
9.
Bove, Riley, Carolyn Bevan, Elizabeth Crabtree, et al.. (2018). Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis. Multiple Sclerosis Journal. 25(11). 1526–1534. 46 indexed citations
10.
Amezcua, Lilyana, Ashley Beecham, Silvia Delgado, et al.. (2018). Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis. Annals of Clinical and Translational Neurology. 5(11). 1362–1371. 20 indexed citations
11.
Baranzini, Sergio E., Egle Cekanaviciute, Justine W. Debelius, et al.. (2017). The MS-Associated Gut Microbiome. CaltechAUTHORS (California Institute of Technology). 1 indexed citations
12.
Sand, Ilana Katz, Sergio E. Baranzini, Rob Knight, et al.. (2015). The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS (P2.205). Neurology. 84(14_supplement). 1 indexed citations
13.
Mowry, Ellen M., A. Beheshtian, Emmanuelle Waubant, et al.. (2009). Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures. Neurology. 72(20). 1760–1765. 57 indexed citations
14.
Okuda, Darin T., Radhika Srinivasan, Jorge R. Oksenberg, et al.. (2008). Genotype–Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain. 132(1). 250–259. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026